| __timestamp | Amicus Therapeutics, Inc. | CymaBay Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 15823000 |
| Thursday, January 1, 2015 | 76943000 | 17026000 |
| Friday, January 1, 2016 | 104793000 | 15941000 |
| Sunday, January 1, 2017 | 149310000 | 18938000 |
| Monday, January 1, 2018 | 270902000 | 58124000 |
| Tuesday, January 1, 2019 | 286378000 | 83837000 |
| Wednesday, January 1, 2020 | 308443000 | 35882000 |
| Friday, January 1, 2021 | 272049000 | 64542000 |
| Saturday, January 1, 2022 | 276677000 | 67995000 |
| Sunday, January 1, 2023 | 152381000 | 80118000 |
Unleashing the power of data
In the dynamic world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Amicus Therapeutics, Inc. and CymaBay Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Amicus Therapeutics consistently outpaced CymaBay in R&D spending, peaking in 2020 with a 547% increase from 2014. In contrast, CymaBay's R&D expenses grew by 406% over the same period, with notable fluctuations. The year 2019 marked CymaBay's highest R&D investment, reaching 8.4 million, a significant leap from its 2014 figures. This disparity highlights Amicus's aggressive pursuit of innovation, while CymaBay's strategy appears more measured. As the biotech landscape evolves, these spending patterns may offer insights into each company's future breakthroughs and market positioning.
Research and Development Expenses Breakdown: Johnson & Johnson vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Novartis AG vs Amicus Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: TG Therapeutics, Inc. vs CymaBay Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. or Amicus Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: CymaBay Therapeutics, Inc. vs Geron Corporation
Rhythm Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Amicus Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Amicus Therapeutics, Inc. and Xencor, Inc.